Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.
Zittermann ArminJ B ErnstS ProkopU FuchsJ DreierJ KuhnH K BertholdS PilzI Gouni-BertholdJ F GummertPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2017)
A daily vitamin D3 dose of 4000 IU did not influence BTMs. Data indicate that vitamin D supplementation will not lower bone turnover in male patients with heart failure.
Keyphrases
- bone mineral density
- postmenopausal women
- heart failure
- body composition
- soft tissue
- study protocol
- clinical trial
- physical activity
- bone loss
- phase iii
- electronic health record
- bone regeneration
- left ventricular
- randomized controlled trial
- phase ii
- big data
- acute heart failure
- cardiac resynchronization therapy
- data analysis
- artificial intelligence